Back to Results
| First Page | Meta Content | |
|---|---|---|
 | Document Date: 2005-05-31 10:09:09Open Document File Size: 856,91 KBShare Result on FacebookCityHYPOCRETIN / Tokyo / Philadelphia / New York / /CompanyProc Natl Acad Sci U S A / Mignot / Lee AG / Matsuda / GE / Medtronic / Hypnion Inc. / HP / Cortex Pharmaceuticals Inc. / Nishino Several / /ContinentEurope / / /EventProduct Issues / Product Recall / /FacilityUniversity of California Los Angeles / DA store / The Robert Wood Johnson Pharmaceutical Research Institute / Showa University Kamijo Hall / National Institute of Health / Howard Hughes Medical Research Institute / / /IndustryTermsimilar device / neuropeptide systems / pharmaceutical industry / treatment of multiple symptoms / stem cell technology / stem-cell technology / dopamine reuptake site / pharmaceutical industry interest / secondary messenger systems / food intake / peptide-receptor systems / Clinical applications / treatment of depression / thalamocortical networks / cholinoceptive site / pharmaceutical / dopamine uptake carrier site / obvious solution / long-term solution / treatment for antibody-mediated diseases / /MedicalConditionhuman and canine narcolepsy / JE / hypocretin deficiency / cocaine abuse / established narcolepsy / hypocretin-deficient human narcolepsy / antibody-mediated diseases / Enterovirus infections / disorder / reverse sleep fragmentation / central cholinergic hypersensitivity / unusually severe cataplexy / narcolepsy / developed cataplexy / hcrtr2-mutated canine narcolepsy / hypersomnias / neurologic disorders / Parkinson’s disease / diseases / In Parkinson disease / canine genetic narcolepsy / Sleep Disorders / depression / recreational sleep deprivation / cataplexy / gamma-hydroxybutyrate withdrawal syndrome / work sleep disorder / nausea / hypersomnia / canine narcolepsy / Canine cataplexy / obesity / cholinergic hypersensitivity / moredistant disease / MS / attention-deficit hyperactivity disorder / human narcolepsy / hypocretin-deficiency narcolepsy / mild and included short-lasting fever / attention-deficit/hyperactivity disorder / I diabetes / insomnia / childhood narcolepsy / attention-deficit/hyperactivity disorders / disease / resistant depression / presumed disease / idiopathic hypersomnia / Couzin J. Diabetes / Parkison disease / Distinct narcolepsy SLEEP / pain / sleep apnea / sleep disorder canine narcolepsy / early onset narcolepsy / postmortem human narcolepsy / withdrawal symptoms / /MedicalTreatmentimmunoglobulin therapy / immunosuppression / catheterization / pharmacotherapy / dialysis / Gene therapy / Plasmapheresis / antidepressant therapies / /OrganizationStanford University Center For Narcolepsy / National Institute on Drug Abuse / 2Stanford Center / Robert Wood Johnson Pharmaceutical Research Institute / NIH NS / Systemic administration / Repeated administration / National Institute of Health / Stanford University School of Medicine / Intranasal administration / Howard Hughes Medical Research Institute / Orexin A / University of California Los Angeles / Stanford / /PersonCutter Kl / Marcel Dekker / Wynne Chen / Arch Neurol / Seiji Nishino / Russell V / Emmanuel Mignot / Ann N Y Acad Sci / / /PositionMartinez PM / Walker / consultant / WB / messenger / Porter / /Productsymptoms / Chlomipramine Tricyclic / Modafinil / ICV injection / Pemoline / Fluoxetine / Desipramine Tricyclic / baclofen / Protryptiline Tricyclic / prednisone / ritalin / venlafaxine / ICV injections / Jittiwutikan J. Amphetamine / Imipramine Tricyclic / Deliv Rev 1995 / SJ / human narcolepsy / narcoleptic dog / Weimaraner / vesicular storage / /RadioStationLeslie FM / Hamalainen AM / Mazarati AM / /RegionScandinavia / /TechnologyNeuroscience / genetic engineering / Drug Delivery / magnetic resonance imaging / dialysis / alpha / antibodies / cloning / transplantation / stem cell technology / stem-cell technology / Gene therapy / pharmacokinetics / http / pharmacodynamics / /URLwww.nhlbi.nih.gov / /SocialTag |